Specify a stock or a cryptocurrency in the search bar to get a summary
Viaderma Inc
VDRMViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Address: 4640 Admiralty Way, Marina del Rey, CA, United States, 90292
Analytics
WallStreet Target Price
–P/E ratio
0.0364Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures VDRM
Dividend Analytics VDRM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VDRM
Stock Valuation VDRM
Financials VDRM
Results | 2019 | Dynamics |